Not applicableStudy completedNCT00897923What this trial is testingImaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's LymphomaWho this might be right forLymphomaSmall Intestine Cancer Mayo Clinic 17
Large-scale testing (Phase 3)Study completedNCT00014391What this trial is testingRibavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell TransplantationWho this might be right forCancer Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Study completedNCT02881086What this trial is testingOptimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified TreatmentWho this might be right forAcute Lymphoblastic LeukemiaLymphoblastic Lymphoma Goethe University 1,023
Testing effectiveness (Phase 2)Study completedNCT01093586What this trial is testingDonor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+73 more Case Comprehensive Cancer Center 14
Not applicableLooking for participantsNCT01137825What this trial is testingRegistry of Older Patients With CancerWho this might be right forChronic Myeloproliferative DisordersCognitive/Functional EffectsLeukemia+6 more UNC Lineberger Comprehensive Cancer Center 3,000
Early research (Phase 1)Study completedNCT00659568What this trial is testingMetformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or LymphomaWho this might be right forBreast CancerEndometrial CancerKidney Cancer+3 more London Health Sciences Centre 28
Large-scale testing (Phase 3)Study completedNCT00438958What this trial is testingSibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other DiseasesWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+3 more The Canadian Blood and Marrow Transplant Group 230
Early research (Phase 1)Study completedNCT00054483What this trial is testingBortezomib in Treating Patients With Advanced Cancer and Kidney DysfunctionWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+31 more National Cancer Institute (NCI) 69
Testing effectiveness (Phase 2)Study completedNCT00053196What this trial is testingDonor Stem Cell Transplant in Treating Patients With Relapsed Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma+3 more Alliance for Clinical Trials in Oncology 82
Not applicableStudy completedNCT00014235What this trial is testingFludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic MalignanciesWho this might be right forAcute Myeloid Leukemia/Transient Myeloproliferative DisorderAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+74 more Fred Hutchinson Cancer Center 160
Early research (Phase 1)Ended earlyNCT00354185What this trial is testingPXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+57 more National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT00004189What this trial is testingRebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced CancerWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT01839916What this trial is testingDonor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+61 more University of Chicago 77
Testing effectiveness (Phase 2)Study completedNCT00357084What this trial is testingMethotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell TransplantWho this might be right forCancer Fred Hutchinson Cancer Center 53
Testing effectiveness (Phase 2)WithdrawnNCT01652014What this trial is testingSingle or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+51 more University of Medicine and Dentistry of New Jersey
Early research (Phase 1)Study completedNCT00049712What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or LymphomaWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific University of Wisconsin, Madison
Large-scale testing (Phase 3)UnknownNCT00003728What this trial is testingCombination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's LymphomaWho this might be right forLeukemiaLymphoma European Organisation for Research and Treatment of Cancer - EORTC 1,500
Testing effectiveness (Phase 2)Study completedNCT00019227What this trial is testingMonoclonal Antibody Therapy in Treating Patients With LeukemiaWho this might be right forLymphomaRadiation Toxicity National Cancer Institute (NCI)
Not applicableStudy completedNCT00248547What this trial is testingAprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell TransplantWho this might be right forCancer OHSU Knight Cancer Institute 40
Testing effectiveness (Phase 2)Study completedNCT00317785What this trial is testingTotal-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other DiseasesWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes Fred Hutchinson Cancer Center 50